Shafiq M, Rafique M, Cui Y, Pan L, Do C-W, Ho EA. An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers. J Control Release. 2023;362:446–67.

Article  CAS  PubMed  Google Scholar 

Uwaezuoke OJ, Kumar P, Pillay V, Choonara YE. Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design. Drug Deliv Transl Res. 2021;11:1903–23.

Article  CAS  PubMed  Google Scholar 

Chen H, Pan H, Li P, Wang H, Wang X, Pan W, Yuan Y. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf B Biointerfaces. 2016;143:455–62.

Article  CAS  PubMed  Google Scholar 

Di Tommaso C, Bourges J-L, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny J-C, Behar-Cohen F, Gurny R, Möller M. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur J Pharm Biopharm. 2012;81:257–64.

Article  PubMed  Google Scholar 

Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 2002;28:353–69.

Article  CAS  PubMed  Google Scholar 

Gupta H, Aqil M, Khar R, Ali A, Bhatnagar A, Mittal G. An alternative in situ gel-formulation of Levofloxacin eye drops for prolong ocular retention. J Pharm Bioallied Sci. 2015;7:9–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedman Z, Allen RC, Raph SM. Topical Acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol. 1985;103:963–6.

Article  CAS  PubMed  Google Scholar 

Tasharrofi N, Nourozi M, Marzban A. How liposomes pave the way for ocular drug delivery after topical administration. J Drug Deliv Sci Technol. 2022;67:103045.

Article  CAS  Google Scholar 

Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993;37(6):435–56.

Article  CAS  PubMed  Google Scholar 

Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. J Control Release. 2023;355:624–54.

Article  CAS  PubMed  Google Scholar 

Souto EB, Macedo AS, Dias-Ferreira J, Cano A, Zielińska A, Matos CM. Elastic and ultradeformable liposomes for transdermal delivery of active pharmaceutical ingredients (APIs). Int J Mol Sci, 22 (2021).

Ghasemiyeh P, Mohammadi-Samani S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des Devel Ther. 2020;14:3271–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbalho GN, Brugger S, Raab C, Lechner J-S, Gratieri T, Keck CM, Rupenthal ID, Agarwal P. Development of transferosomes for topical ocular drug delivery of Curcumin. Eur J Pharm Biopharm. 2024;205:114535.

Article  CAS  PubMed  Google Scholar 

Zheng W-s, Fang X-q, Wang L-l, Zhang Y-j. Preparation and quality assessment of Itraconazole transfersomes. Int J Pharm. 2012;436:291–8.

Article  CAS  PubMed  Google Scholar 

Matharoo N, Mohd H, Michniak-Kohn B. Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments, WIREs Nanomed Nanobiotechnol, 16 (2024) e1918.

Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the Art. Nano Rev Exp. 2017;8:1325708.

Article  PubMed  PubMed Central  Google Scholar 

Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104:226–32.

Article  CAS  PubMed  Google Scholar 

Mazyed EA, Abdelaziz AE. Fabrication of transgelosomes for enhancing the ocular delivery of Acetazolamide: statistical optimization, in vitro characterization, and in vivo study. Pharmaceutics; 2020. p. 12.

Uwaezuoke O, Du Toit LC, Kumar P, Ally N, Choonara YE. Linoleic acid-based transferosomes for topical ocular delivery of cyclosporine A, Pharmaceutics, 14 (2022).

Srivastava V, Patil RK, Mehra NK. A one-platform comparison study of brinzolamide-loaded liposomes, niosomes, transfersomes, and transniosomes for better management of glaucoma. Int J Pharm. 2024;666:124741.

Article  CAS  PubMed  Google Scholar 

Bukowiecki A, Hos D, Cursiefen C, Eming SA. Wound-healing studies in cornea and skin: parallels, differences and opportunities. Int J Mol Sci, 18 (2017).

Edelhauser HF. The balance between corneal transparency and edema the proctor lecture. Invest Ophthalmol Vis Sci. 2006;47:1755–67.

Article  Google Scholar 

Candia OA, Alvarez LJ, Dartt DA. Overview of electrolyte and fluid transport across the conjunctiva, in: reference module in neuroscience and biobehavioral psychology. Elsevier; 2017.

Bill A. Movement of albumin and dextran through the sclera. Arch Ophthalmol. 1965;74:248–52.

Article  CAS  PubMed  Google Scholar 

PubChem. PubChem compound summary for CID 6918324, tonabersat, in, 2024.

Bhujbal S, Rupenthal ID, Agarwal P. Development and validation of stability-indicating HPLC method for assay of tonabersat in pharmaceutical formulations, Methods, (2024).

Lyon H, Shome A, Rupenthal ID, Green CR, Mugisho OO. Tonabersat inhibits connexin43 hemichannel opening and inflammasome activation in an in vitro retinal epithelial cell model of diabetic retinopathy. Int J Mol Sci, 22 (2020).

Mugisho OO, Aryal J, Shome A, Lyon H, Acosta ML, Green CR, Rupenthal ID. Orally delivered connexin43 hemichannel blocker, Tonabersat, inhibits vascular breakdown and inflammasome activation in a mouse model of diabetic retinopathy. Int J Mol Sci. 2023;24:3876.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y, Griffin JM, Nor MNM, Zhang J, Freestone PS, Danesh-Meyer HV, Rupenthal ID, Acosta M, Nicholson LFB, O’Carroll SJ, Green CR. Tonabersat prevents inflammatory damage in the central nervous system by blocking connexin43 hemichannels, Neurother, 14 (2017) 1148–1165.

Bhujbal S, Rupenthal ID, Agarwal P. Formulation and characterization of transferosomes for ocular delivery of Tonabersat. Phar, Dev Technol. 2025. https://doi.org/10.1080/10837450.2025.2501991

Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Release. 2006;111:145–52.

Article  CAS  PubMed  Google Scholar 

Jurišić Dukovski B, Ljubica J, Kocbek P, Safundžić Kučuk M, Krtalić I, Hafner A, Pepić I, Lovrić J. Towards the development of a biorelevant in vitro method for the prediction of nanoemulsion stability on the ocular surface. Int J Pharm. 2023;633:122622.

Article  PubMed  Google Scholar 

Luepke NP. Hen’s egg Chorioallantoic membrane test for irritation potential. Food Chem Toxicol. 1985;23:287–91.

Article  CAS  PubMed  Google Scholar 

Lorentz H, Heynen M, Kay LM, Dominici CY, Khan W, Ng WW, Jones L. Contact lens physical properties and lipid deposition in a novel characterized artificial tear solution. Mol Vis. 2011;17:3392–405.

CAS  PubMed  PubMed Central  Google Scholar 

OECD, Test No. 437: bovine corneal opacity and permeability test method for identifying i) chemicals inducing serious eye damage and Ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage, 2023.

Agarwal P, Scherer D, Günther B, Rupenthal ID. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs. Int J Pharm. 2018;538:119–29.

Article  CAS  PubMed  Google Scholar 

Abdelkader H, Ismail S, Hussein A, Wu Z, Al-Kassas R, Alany RG. Conjunctival and corneal tolerability assessment of ocular Naltrexone niosomes and their ingredients on the Hen’s egg Chorioallantoic membrane and excised bovine cornea models. Int J Pharm. 2012;432:1–10.

Article  CAS  PubMed  Google Scholar 

Bruner LH, Kain DJ, Roberts DA, Parker RD. Evaluation of seven in vitro alternatives for ocular safety testing. Fundam Appl Toxicol. 1991;17:136–49.

Article  CAS  PubMed  Google Scholar 

Agarwal P, Khun D, Krösser S, Eickhoff K, Wells FS, Willmott GR, Craig JP, Rupenthal ID. Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics. Ocul Surf. 2019;17:241–9.

Article  PubMed  Google Scholar 

Barbalho GN, Falcão MA, Lopes JMS, Lopes JM, Contarato JLA, Gelfuso GM, Cunha-Filho M, Gratieri T. Dynamic ex vivo Porcine eye model to measure ophthalmic drug penetration under simulated lacrimal flow. Pharmaceutics. 2023;15:2325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah AM, Galor A. Impact of ocular surface temperature on tear characteristics: current insights. Clin Optom (Auckl). 2021;13:51–62.

Article